Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joshua Vitlip
Observed name:
J. Vitlip
OpenAlex ID:
A5114565675
Sul048 S-4321, A NOVEL DUAL-CELL BIFUNCTIONAL PD-1:FCyRIIB SELECTIVE AGONIST ANTIBODY FOR THE TREATMENT OF IMMUNE-MEDIATED AND AUTOIMMUNE DISEASES, MAINTAINS PD-1 EXPRESSION, DOES NOT DEPLETE T CELLS AND ENHANCES INHIBITORY RECEPTOR EXPRESSION IN VIVO
2026
·
Julia Manasson
, Michael Cianci
, et al.
·
Gastroenterology
·
1
Multi-Mechanistic Approaches to Disarming IgE-Mediated Allergic Diseases 2304105
2026
·
Purvi Mande
, Allison Colthart
, et al.
·
The Journal of Immunology
PDF
S-4321 Is a Novel, Non-Depleting, Bifunctional PD-1:FcγRIIB Selective Agonist Antibody for the Treatment of Immune-Mediated Diseases 2333621
2026
·
Daniela Cipolletta
, Julia Manasson
, et al.
·
The Journal of Immunology
PDF
Discovery and validation of novel IgA proteases for the treatment of autoimmune and inflammatory diseases 2328257
2026
·
Joshua Vitlip
, Daniela Cipolletta
, et al.
·
The Journal of Immunology
0057 S-4321 is a novel, non-depleting, bifunctional PD-1:FcγRIIb selective agonist antibody for the treatment of immune-mediated diseases
2026
·
A. Pellerin
, M. Cosenza
, et al.
·
Journal of Investigative Dermatology
Sul048 S-4321, A NOVEL DUAL-CELL BIFUNCTIONAL PD-1:FCyRIIB SELECTIVE AGONIST ANTIBODY FOR THE TREATMENT OF IMMUNE-MEDIATED AND AUTOIMMUNE DISEASES, MAINTAINS PD-1 EXPRESSION, DOES NOT DEPLETE T CELLS AND ENHANCES INHIBITORY RECEPTOR EXPRESSION IN VIVO
2026
·
Julia Manasson
, Michael Cianci
, et al.
·
Gastrointestinal Endoscopy
Identification and characterization of PD-1 agonists for the treatment of autoimmune and inflammatory diseases
2024
·
Maria Ramello
, Stephanie Grebinoski
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
7
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
